| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8238571 | International Journal of Radiation Oncology*Biology*Physics | 2008 | 8 Pages |
Abstract
Clinically achievable concentrations of 17AAG can decrease the radioresistance intrinsic to vascular ECs and minimize the radioprotection conferred upon them by tumor-derived growth factors. These findings characterize 17AAG as a promising radiosensitizer for the tumor vasculature.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Alexander E. Ph.D., Yulia M. M.Sc., Yana V. M.Sc.,